How many insider declarations does Ocumension Therapeutics - B have?

Ocumension Therapeutics - B has filed 2 insider declarations with HKEX.

Who is the top reporting insider at Ocumension Therapeutics - B?

The top reporting insider at Ocumension Therapeutics - B is Hu Zhaopeng, based on the count of public filings.

Across the available history, declared buys total 0 and disposals 0.

FY ended December 2025 · cache

6.36 €

Analyst consensus

2 analysts

·

8.95 €Target 9.60 €(+51%)10.26 €

Income statement

Revenue804.4 M€

Gross profit360.9 M€45% margin

Net income−158.8 M€-19.7% margin

Valuation

PER (forward)25.4x

P/Book1.2x

Beta0.48

Balance sheet & cash

Market cap5.11 Bn€

Total debt187.5 M€

Free Cash Flow−358.7 M€

Debt / Equity5%

Profitability & ownership

ROE-4.3%

ROA-2.5%

% insiders49.0%

% institutions12.3%

Last declaration on 1 April 2026